Skip to content

Earnings yield at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.4%-1.1pp
Bausch + Lomb logo
Bausch + LombBLCO
-3.9%-1.2pp
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-1.6%-0.7pp
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-9.9%-4.8pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-29.6%+144pp
PBH
Prestige Consumer HealthcarePBH
6.8%+1.7pp

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.21B+58.2%
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Calculated from Ocular Therapeutix’s reported figures.

Based on trailing twelve months.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's earnings yield?
Ocular Therapeutix (OCUL) reported earnings yield of -15.8% in Q1 2026.
How has Ocular Therapeutix's earnings yield changed year-over-year?
Ocular Therapeutix's earnings yield increased by 4.7% year-over-year, from -16.5% to -15.8%.
What is the long-term trend for Ocular Therapeutix's earnings yield?
Over 5 years (2020 to 2025), Ocular Therapeutix's earnings yield has grown at a 0.9% compound annual growth rate (CAGR), from -9.8% to -10.3%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.